DHR has been in the news 643% more than usual
Feb 18, 2026, 7:34 PM
-8.53%
What does DHR do
Danaher, headquartered in Washington, D.C., employs 61,000 people and operates in Biotechnology, Life Sciences, and Diagnostics, offering products and services for medical and industrial applications.
DHR has been in the news recently: Danaher agreed to buy medical-device maker Masimo for $180 a share—about $9.9 billion in enterprise value—yet Danaher’s stock fell more than 3.5% amid a 2026 decline exceeding 10%. The acquisition comes two years after activist hedge fund Politan Capital Management led a proxy contest that removed Masimo founder Joe Kiani as board chair.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.